Amedica Corporation (AMDA) : The bears are holding on to their shorts in Accenture Plc with 2 more days remaining for them to cover their positions. The bearish positions have increased from 990,520 on Jul 29, 2016, to 1,205,560, on August 15, 2016. Daily, 762,221 shares are traded, which shows the high interest of the traders in the stock. The net addition of short open interest is 215,040 shares, which is an increase of just 21.7%. The total short interest of 6.5% of the float indicates that there arent many bears on this stock at the current prices. The short interest information was released on Wednesday Aug 24th after the market close.
Amedica Corporation (NASDAQ:AMDA): The stock opened at $1.23 on Wednesday but the bulls could not build on the opening and the stock topped out at $1.32 for the day. The stock traded down to $1.05 during the day, due to lack of any buying support eventually closed down at $1.12 with a loss of -3.45% for the day. The stock had closed at $1.16 on the previous day. The total traded volume was 17,680,231 shares.
In a related news, Lombardi Ty, officer (VP Finance) of Amedica Corp, had purchased 25,000 shares on September 10, 2015. The total value of the transaction was $10,000. The information was disclosed with the SEC in a Form 4 Filing. The information is based on open market trades at the market prices.Option exercises are not covered.
Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer focused on using its silicon nitride technology platform to develop, manufacture and sell a range of medical devices. The Company markets spinal fusion products and are developing products for use in total hip and knee joint replacements. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States and Europe for use in the cervical and thoracolumbar areas of the spine. The Companys Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Cervical and Corpectomy. In addition to its silicon nitride-based spinal fusion products, the Company markets a line of non-silicon nitride spinal fusion products, which allows it to provide surgeons and hospitals with a range of products.